# Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)

Study · id `cardio:ct-nct07611747` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07611747](<https://clinicaltrials.gov/study/NCT07611747>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07611747

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1944 participants.

## Technical summary

Registry record NCT07611747. Randomized; no masking; primary purpose prevention. Start 2026-04-22 (actual); primary completion 2031-04-22 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1944 participants (planned count; ClinicalTrials.gov record NCT07611747, source copy `cardio:ctgov-nct07611747-2026-11-10`, retrieved 2026-11-18)
- Started: 2026-04-22 (actual) (ClinicalTrials.gov record NCT07611747, source copy `cardio:ctgov-nct07611747-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2031-04-22 (anticipated) (ClinicalTrials.gov record NCT07611747, source copy `cardio:ctgov-nct07611747-2026-11-10`, retrieved 2026-11-18)
- Completion: 2031-12 (anticipated) (ClinicalTrials.gov record NCT07611747, source copy `cardio:ctgov-nct07611747-2026-11-10`, retrieved 2026-11-18)
- Countries: Spain (ClinicalTrials.gov record NCT07611747, source copy `cardio:ctgov-nct07611747-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07611747-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
- Acronym: PREVENER
- Condition: Rheumatoid Arthritis (RA)
- Condition: Psoriatic Arthritis (PsA)
- Condition: Systemic Lupus Erythematosus (SLE)
- Condition: Carotid Artery Diseases
- Condition: Cardio Vascular Disease
- Condition: Atheroscleroses
- Condition: Axial Spondyloarthritis
- Intervention (Diagnostic test): Carotid Ultrasound
- Intervention (Drug): High-intensity lipid-lowering therapy
- Intervention (Other): Standard care according to ESC 2021 guidelines
- Lead sponsor: Instituto de Investigación Marqués de Valdecilla
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: Instituto de Investigación Marqués de Valdecilla (`cardio:org-instituto-de-investigacion-marques-de-valdecilla`)

## Provenance

Content hash: 4720c44743f7fd8646162f86394779c995a62d594348bd1ba54920e149c95503
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
